Article Information
History
- July 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Guruduth Banavar1,*,
- Oyetunji Ogundijo1,
- Cristina Julian1,
- Ryan Toma1,
- Francine Camacho1,
- Pedro J. Torres1,
- Lan Hu1,
- Liz Kenny2,
- Sarju Vasani3,
- Martin Batstone4,
- Nevenka Dimitrova5,
- Momchilo Vuyisich1,
- Salomon Amar5 and
- Chamindie Punyadeera6,7,*
- 1Viome Research Institute, Viome Life Science Inc, Seattle and New York City, USA
- 2Royal Brisbane and Women’s Hospital and The School of Medicine, University of Queensland, Brisbane, QLD, Australia
- 3Department of Otolaryngology, Royal Brisbane and Women’s Hospital and Faculty of Medicine, University of Queensland, Herston, QLD, Australia
- 4Oral and Maxillofacial Surgery Department, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia
- 5New York Medical College, Valhalla, NY, USA
- 6The Saliva and Liquid Biopsy Translational Laboratory, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD, Australia
- 7Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia
- ↵*Corresponding authors: G.B. guru{at}viome.com and C.P. c.punyadeera{at}griffith.edu.au